CVS Health Corp (CVS) Holdings Cut by Flagship Harbor Advisors LLC
Flagship Harbor Advisors LLC cut its position in CVS Health Corp (NYSE:CVS) by 11.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 12,815 shares of the pharmacy operator’s stock after selling 1,725 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in CVS Health were worth $1,001,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of the business. Walter & Keenan Financial Consulting Co. MI ADV raised its holdings in shares of CVS Health by 5.0% during the fourth quarter. Walter & Keenan Financial Consulting Co. MI ADV now owns 14,280 shares of the pharmacy operator’s stock valued at $1,035,000 after purchasing an additional 680 shares during the last quarter. Franklin Parlapiano Turner & Welch LLC raised its holdings in shares of CVS Health by 6.8% during the fourth quarter. Franklin Parlapiano Turner & Welch LLC now owns 53,246 shares of the pharmacy operator’s stock valued at $3,860,000 after purchasing an additional 3,367 shares during the last quarter. Northpointe Capital LLC purchased a new position in shares of CVS Health during the fourth quarter valued at approximately $4,373,000. Cerebellum GP LLC purchased a new position in shares of CVS Health during the fourth quarter valued at approximately $130,000. Finally, Duncker Streett & Co. Inc. raised its holdings in shares of CVS Health by 24.5% during the fourth quarter. Duncker Streett & Co. Inc. now owns 39,311 shares of the pharmacy operator’s stock valued at $2,850,000 after purchasing an additional 7,726 shares during the last quarter. 83.23% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently weighed in on CVS. Robert W. Baird decreased their price objective on shares of CVS Health from $85.00 to $80.00 and set a “neutral” rating for the company in a report on Friday, February 9th. ValuEngine cut shares of CVS Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Bank of America began coverage on shares of CVS Health in a report on Tuesday, February 27th. They set a “buy” rating and a $91.00 price objective for the company. Vetr cut shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 price objective for the company. in a report on Thursday, January 4th. Finally, SunTrust Banks boosted their price objective on shares of CVS Health to $90.00 and gave the company a “buy” rating in a report on Friday, January 5th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $87.03.
Shares of CVS Health Corp (NYSE:CVS) opened at $67.46 on Friday. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59. The stock has a market cap of $68,440.33, a P/E ratio of 10.43, a P/E/G ratio of 1.12 and a beta of 1.03. CVS Health Corp has a 12-month low of $66.45 and a 12-month high of $84.00.
CVS Health (NYSE:CVS) last announced its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion during the quarter, compared to analyst estimates of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.71 earnings per share. equities analysts predict that CVS Health Corp will post 6.37 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th were given a $0.50 dividend. The ex-dividend date was Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.96%. CVS Health’s payout ratio is currently 30.91%.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.